BN-80245

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBN-80245
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase inhibitorsDNA topoisomerase I inhibitors
TargetsDNA topoisomerase IDNA topoisomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsenIpsen Pharma Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen Pharma SasIpsen
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A